Rivaroxaban

Overview

Rivaroxaban (Xarelto; BAY 59-7939) is a novel, oral, direct Factor Xa (FXa) inhibitor in late-stage development for the prevention and treatment of thromboembolic disorders.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cardiovascular and blood system | Factor Xa

Product Information

• Catalog No.: B0084-067210
• CAS No.: 366789-02-8
• Molecular Formula: C19H18ClN3O5S
• Molecular Weight: 435.879
• Purity: >99%

Source

Original product source